ABSTRACT
Background@#Reports on metastatic or invasive infections by hypervirulent Klebsiella pneumoniae (hvKP) have increased recently. However, the effects of its virulence on clinical course and outcomes in pneumonia patients have rarely been addressed. We assessed and compared the clinical features of hvKp and classic K. pneumoniae (cKP) strains isolated from patients with pneumonia caused by K. pneumoniae. We also investigated the effects of virulence factors and the K. pneumoniae capsular serotypes K1 and K2 on mortality. @*Methods@#In this retrospective study, we enrolled 91 patients diagnosed as having pneumonia caused by K. pneumoniae and obtained their demographic and clinical data from medical records. We evaluated genes for K1 and K2, antimicrobial susceptibility, and the virulence genes rmpA, iutA, entB, ybtS, kfu, mrkD, and allS. Strains that possessed rmpA and iutA were defined as hvKP (N=39), while the remaining were classified as cKP (N=52).Odds ratio (OR) for the risk factors associated with 30-day mortality was calculated using the binary logistic regression model. @*Results@#The 30-day mortality in all patients was 23.1%; it was 17.9% (7/39) in the hvKP group and 26.9% (14/52) in the cKP group (P = 0.315). Bacteremia (OR = 38.1; 95% confidence interval [CI], 2.5–570.2), altered mental status (OR = 8.8; 95% CI, 1.7–45.0), and respiratory rate > 30 breaths/min (OR = 4.8; 95% CI, 1.2–20.0) were independent risk factors for 30-day mortality in all patients. @*Conclusions@#Our results suggest that hypervirulence determinants do not have a significant effect on 30-day mortality in patients with pneumonia caused by K. pneumoniae.
ABSTRACT
Non-Hodgkin's lymphoma of B-cell type is the second most common neoplasm after Kaposi's sarcoma among patients with human immunodeficiency virus infection. Most non-Hodgkin's lymphoma cases that are associated with acquired immunodeficiency syndrome (AIDS) involve extranodal sites, especially the digestive tract and the central nervous system. We report a case of multiple jejunal intussusception caused by Burkitt lymphoma in a 42-year-old AIDS patient. Upper gastrointestinal endoscopy and surgical biopsy were performed and a complete diagnostic study including histological and immunohistochemical analyses showed Burkitt lymphoma.
Subject(s)
Adult , Humans , Acquired Immunodeficiency Syndrome , B-Lymphocytes , Biopsy , Burkitt Lymphoma , Central Nervous System , Endoscopy, Gastrointestinal , Gastrointestinal Tract , HIV , Intussusception , Lymphoma, Non-Hodgkin , Sarcoma, KaposiABSTRACT
Non-Hodgkin's lymphoma of B-cell type is the second most common neoplasm after Kaposi's sarcoma among patients with human immunodeficiency virus infection. Most non-Hodgkin's lymphoma cases that are associated with acquired immunodeficiency syndrome (AIDS) involve extranodal sites, especially the digestive tract and the central nervous system. We report a case of multiple jejunal intussusception caused by Burkitt lymphoma in a 42-year-old AIDS patient. Upper gastrointestinal endoscopy and surgical biopsy were performed and a complete diagnostic study including histological and immunohistochemical analyses showed Burkitt lymphoma.
Subject(s)
Adult , Humans , Acquired Immunodeficiency Syndrome , B-Lymphocytes , Biopsy , Burkitt Lymphoma , Central Nervous System , Endoscopy, Gastrointestinal , Gastrointestinal Tract , HIV , Intussusception , Lymphoma, Non-Hodgkin , Sarcoma, KaposiABSTRACT
No abstract available.
ABSTRACT
No abstract available.
ABSTRACT
Acute cholecystitis is a rare complication of scrub typhus. Although a few such cases have been reported in patients with scrub typhus, the clinical course is not well described. Of 12 patients, acute cholecystitis developed in 66.7% (8/12) of patients older than 60 yr. The scrub typhus group with acute cholecystitis had marginal significant longer hospital stay and higher cost than the group without cholecystitis according to propensity score matching. Scrub typhus should be kept in mind as a rare etiology of acute cholecystitis in endemic areas because the typical signs of scrub typhus such as skin rash and eschar can present after the abdominal pain.
Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Cholecystitis, Acute/diagnosis , Diagnosis, Differential , Republic of Korea , Scrub Typhus/complications , Treatment OutcomeABSTRACT
No abstract available.
Subject(s)
Aged , Female , Humans , Male , Middle Aged , Administration, Oral , Anti-Bacterial Agents/administration & dosage , Bone Diseases, Infectious/diagnosis , Drug Therapy, Combination , Hospitals, University , Joint Diseases/diagnosis , Microbial Sensitivity Tests , Republic of Korea , Staphylococcal Infections/diagnosis , Staphylococcus aureus/drug effects , Treatment OutcomeABSTRACT
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of ear infections. We attempted to evaluate the clinical usefulness of arbekacin in treating chronic suppurative otitis media (CSOM) by comparing its clinical efficacy and toxicity with those of vancomycin. Efficacy was classified according to bacterial elimination or bacteriologic failure and improved or failed clinical efficacy response. Ninety-five subjects were diagnosed with CSOM caused by MRSA. Twenty of these subjects were treated with arbekacin, and 36 with vancomycin. The bacteriological efficacy (bacterial elimination, arbekacin vs. vancomycin: 85.0% vs. 97.2%) and improved clinical efficacy (arbekacin vs. vancomycin; 90.0% vs. 97.2%) were not different between the two groups. However, the rate of complications was higher in the vancomycin group (33.3%) than in the arbekacin group (5.0%) (P=0.020). In addition, a total of 12 adverse reactions were observed in the vancomycin group; two for hepatotoxicity, one for nephrotoxicity, eight for leukopenia, two for skin rash, and one for drug fever. It is suggested that arbekacin be a good alternative drug to vancomycin in treatment of CSOM caused by MRSA.
Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Anti-Bacterial Agents/administration & dosage , Chronic Disease , Dibekacin/administration & dosage , Methicillin-Resistant Staphylococcus aureus/drug effects , Otitis Media, Suppurative/diagnosis , Staphylococcal Infections/diagnosis , Treatment Outcome , Vancomycin/administration & dosageABSTRACT
No abstract available.
Subject(s)
Animals , Humans , Anaplasmosis , Korea , Scrub Typhus , SeasonsABSTRACT
Chikungunya is caused by an arbovirus transmitted by Aedes mosquito vector. With the increase of habitat of mosquito by global warming and frequent international travel and interchange, chikungunya reemerged and showed global distribution recently. Until now there has not been reported any case infected with chikungunya virus in Korea. A 23-year-old man has been the Republic of the Philippines for 1 week, and visited our emergency center due to fever and back pain. Chikungunya viral infection was diagnosed by specific IgM for chickungunya virus by enzyme-linked immunosorbent assayin Korea Centers for Disease Control and Prevention. His clinical course was self limited. We introduce the first imported case infected with chikungunya virus in Korea.
Subject(s)
Humans , Young Adult , Aedes , Arboviruses , Back Pain , Chikungunya virus , Culicidae , Ecosystem , Emergencies , Fever , Global Warming , Immunoglobulin M , Korea , PhilippinesABSTRACT
Korea is a low prevalence country for human immunodeficiency virus (HIV) infection and has an intermediate tuberculosis (TB) burden. We previously reported that the incidence of TB in HIV-infected patients was 9.6 cases per 100 person-years (P-Y) between 1988 and 1997. The aims of the present study were to measure any change in incidence from the previous study, and to identify risk factors for TB in HIV-infected patients. We reviewed all medical records of HIV-infected patients who were followed-up in one tertiary hospital between 1998 and 2010. Over the total observation period of 5858.33 P-Y, TB developed in 70 patients (1.19 cases per 100 P-Y; 95% confidence interval [CI], 0.91-1.47 cases per 100 P-Y). Based on Poisson regression, one risk factor associated with TB was an initial CD4+ cell count below 200 cells/microliter (relative risk, 2.34; 95% CI, 1.47-3.73). Mean CD4+ cell counts of pulmonary, extrapulmonary, and both pulmonary and extrapulmonary TB were 179.8 cells/microliter, 138.3 cells/microliter, and 114.2 cells/microliter, respectively (P = 0.55). In conclusion, the incidence of TB in HIV-infected patients has decreased since the previous study. An initial CD4+ cell count below 200 cells/microliter is an independent risk factor for development of TB in HIV-infected patients.
Subject(s)
Adult , Female , Humans , Male , Middle Aged , CD4 Lymphocyte Count , HIV Infections/complications , Incidence , Retrospective Studies , Risk Factors , Tuberculosis/complicationsABSTRACT
We evaluated risk factors for neutropenic fever and febrile prolonged neutropenia during vincristine-including chemotherapy to treat HIV-related lymphoma to investigate whether protease inhibitor (PI) treatment is associated with infectious complications due to drug interactions with chemotherapeutic agents. We included all HIV patients who received chemotherapy including vincristine for lymphoma at a single referral center in 1999-2010. Neutropenic fever was defined as absolute neutrophil count < 500 cells/microL with body temperature over 38degrees C; and prolonged neutropenia was defined if it persisted over 7 days. CODOX-M/IVAC and Stanford regimens were considered high-risk regimens for prolonged neutropenia. We analyzed 48 cycles of chemotherapy in 17 HIV patients with lymphoma. There were 22 neutropenic fever and 12 febrile prolonged neutropenia events. In multivariate analysis, neutropenic fever was associated with old age and low CD4 cell count, but not with PI use or ritonavir-boosted PI use. Low CD4 cell count and high-risk regimens were associated with febrile prolonged neutropenia. Neutropenic fever and febrile prolonged neutropenia is associated with old age, low CD4 cell count, and high-risk regimens, but not PI use, in HIV patients undergoing chemotherapy including vincristine for lymphoma.
Subject(s)
Adult , Humans , Male , Middle Aged , Age Factors , Antineoplastic Agents, Phytogenic/therapeutic use , Body Temperature , CD4 Lymphocyte Count , Fever/etiology , HIV Infections/complications , Lymphoma, AIDS-Related/complications , Multivariate Analysis , Neutropenia/etiology , Retrospective Studies , Risk Factors , Vincristine/therapeutic useABSTRACT
BACKGROUND: Local epidemiologic data on prevalent pathogens are important to guide empirical antibiotic therapy. In this study, we observed annual changes in frequency of occurrence and in vitro antimicrobial susceptibility of blood isolates over a period of 13 years. MATERIALS AND METHODS: We reviewed blood isolates identified during the period from 1998 to 2010 at Seoul National University Hospital. Only first isolates for each patient were included in the analysis. We analyzed the frequency of isolates and their trend with regard to in vitro antimicrobial susceptibility. Data were presented according to guidelines of the Clinical and Laboratory Standards Institute (CLSI) (2009). RESULTS: A total of 23,501 isolates were identified during the period from 1998 to 2010. Fifty-five percent of the isolates were gram-positive cocci, 38% were gram-negative rods, and 3% were fungi. Coagulase-negative Staphylococcus (CoNS) (24%), Escherichia coli (16%), Staphylococcus aureus (10%), and Klebsiella pneumoniae (8%) were the most commonly isolated bacteria, and Candida albicans (2%) was the most commonly isolated fungus. The frequency of CoNS increased from 18.0% to 26.8%, whereas the frequency of E. coli and K. pneumoniae decreased from 20.2% to 13.7% and from 11.7% to 6.7%, respectively. Overall, the proportion of methicillin-resistant S. aureus changed from 47.9% to 62.1%. In E. coli, the resistance rate of cefotaxime and ciprofloxacin increased over a period of 13 years. However, such an increase of resistance was not observed in K. pneumoniae. In P. aeruginosa, and particularly in A. baumannii, resistance to imipenem rose alarmingly (3% in 1998 to 27.8% in 2010, 5% in 1998 to 68.9% in 2010, respectively). CONCLUSIONS: Over the last 13 years, the proportion of CoNS in blood isolates increased, which led to a relative decrease of isolated gram-negative rods. Proportions of MRSA showed no significant change, whereas cefotaxime resistant and ciprofloxacin resistant E. coli increased. Imipenem resistant P. aeruginosa and A. baumannii also increased during the study period.
Subject(s)
Humans , Bacteremia , Bacteria , Candida albicans , Cefotaxime , Ciprofloxacin , Escherichia coli , Fungi , Gram-Positive Cocci , Imipenem , Klebsiella pneumoniae , Methicillin Resistance , Methicillin-Resistant Staphylococcus aureus , Pneumonia , Republic of Korea , Staphylococcus , Staphylococcus aureusABSTRACT
No abstract available.
Subject(s)
Humans , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza, Human/diagnosisABSTRACT
Human brucellosis is a newly emerging infectious disease in Korea, and the number of the patients with this disease has rapidly increased in recent years. To evaluate the most reliable method in diagnosing human brucellosis, a retrospective study was conducted. Medical records of patients admitted or followed-up at the outpatient department of a tertiary care university hospital during the past 5 years were reviewed. Among a total of 32 human brucellosis patients (24 males and 8 females), 21 (65.6%) were positive for standard tube agglutination test (STA) but negative for blood or bone marrow culture, 7 (21.9%) were positive for both STA and culture, and 4 (12.5%) were STA negative but culture positive. Based on these findings, we recommend that physicians include blood and/or bone marrow culture to obtain definitive diagnosis when clinical symptoms and signs strongly suggest the human brucellosis, even when STA is negative.
Subject(s)
Humans , Male , Agglutination Tests , Bone Marrow , Brucellosis , Communicable Diseases, Emerging , Korea , Medical Records , Outpatients , Retrospective Studies , Tertiary HealthcareABSTRACT
BACKGROUND/AIMS: Medical students face the threat of acquiring blood-borne infections such as HIV, Hepatitis B and Hepatitis C during their clinical activities in clerkship. This study determined the frequency of exposure and the risks of exposure to blood and body fluids among medical students. METHODS: An anonymous questionnaire was administrated to the 4th year medical students in a tertiary academy university hospital. RESULTS: The surveys were completed by 124 students (100% of the students). Seventy-one percent (88 cases) reported more than one time of exposure to blood or body fluids during the consecutive 2 years of clinical rotation. Single needle stick injury occurred for 19.3% of the students, both exposure to needle stick and splash occurred for 40.9% and single splash occurred for 39.8% of the 88 cases. Venipucture was the highest exposure event (50%), and the other causes were scrub (35.2%), bedside procedures (35.2%), arterial puncture (22.7%), lancet (13.6%), suture (5.7%) and others (8%). The emergency department had the highest exposures rate (80.7%), and this was followed by general surgery (33%), neurosurgery (8%), orthopedic surgery (8%), plastic surgery (6.8%), obstetrics-gynecology (5.7%) and others (10.1%). The major exposure sites in the hospital were the emergency room (81.8%), operation room (38.6%), intensive care unit (8%), general ward (6.8%) and others (2.3%). Only nineteen cases (21.6%) of hospital exposure were reported to the appropriate medical personnel. CONCLUSIONS: This study shows medical students have the potential risk of health care related infection when they are exposed to many patients in the emergency department without a supervisor being present. To avoid the occurrence of these problems, preventive education, and particularly the practice of universal precaution, should be taken by the medical students before beginning their clinical activity.